Merck | MRK - Loan Capital

Stock Price
117.75
Daily Change
0.40 0.34%
Monthly
0.17%
Yearly
2.39%
Q2 Forecast
114.30

Merck reported EUR10.8B in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Adidas EUR 4.34B 32M Mar/2026
Adyen EUR 183.27M 8.2M Dec/2025
Akzo Nobel EUR 4.76B 1.09B Mar/2026
Alcon AG USD 4.16B 434M Mar/2026
Amadeus IT EUR 2.54B 1.8M Mar/2026
AstraZeneca USD 25.96B 177M Mar/2026
BASF EUR 18.48B 447M Dec/2025
Bayer EUR 30.68B 1.15B Mar/2026
Beiersdorf EUR 117M 15M Dec/2025
Covestro EUR 1.67B 408M Dec/2025
Danone EUR 10.07B 501M Dec/2025
Fresenius EUR 9.22B 1.58B Dec/2025
Fresenius Medical Care EUR 5.74B 895.27M Mar/2026
Genmab DKK 5.14B 5.01B Dec/2025
Givaudan CHF 4.19B 448M Dec/2025
GlaxoSmithKline GBP 14.01B 696M Mar/2026
GRIFOLS EUR 9.08B 612M Mar/2026
Henkel EUR 1.38B 627M Dec/2025
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Infineon EUR 6.4B 621M Mar/2026
Lakefront Biotherapeutics EUR 4.85M 335K Mar/2026
Linde USD 20.68B 2.09B Dec/2025
Lonza CHF 3.88B 323M Dec/2025
Merck EUR 10.8B 72M Mar/2026
Novartis USD 37.45B 7.86B Mar/2026
Philips EUR 6.89B 43M Mar/2026
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 13.84B 1.88B Mar/2026
UCB EUR 2.18B 634M Dec/2025